デフォルト表紙
市場調査レポート
商品コード
1518340

タンパク質発現市場:システム別、オファリング別、用途別、エンドユーザー別 - 2030年までの世界予測

Protein Expression Market by System (Mammalian, Non-mammalian ), Offering (Kits & Reagents, Vectors, Competent Cells, Services), Application (Industrial, Therapeutic, Research), and End User - Global Forecast to 2030


出版日
ページ情報
英文 270 Pages
納期
5~7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.42円
タンパク質発現市場:システム別、オファリング別、用途別、エンドユーザー別 - 2030年までの世界予測
出版日: 2024年07月01日
発行: Meticulous Research
ページ情報: 英文 270 Pages
納期: 5~7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

タンパク質発現市場は、2023年から2030年までのCAGRが7.6%で、2030年までに50億米ドルに達すると予測されています。

広範な2次調査と1次調査、市場シナリオの詳細な分析を経て、当レポートは主要な業界促進要因、抑制要因、機会、課題の分析を提供します。

バイオ医薬品市場の成長、組換えタンパク質に対する需要の高まり、政府の支援策、ライフサイエンス研究への資金援助がこの市場の成長を促進しています。しかし、タンパク質ベースの研究にかかるコストの高さと熟練した専門家の不足が、この市場の成長を抑制しています。さらに新興国は、タンパク質発現市場で活動する企業に大きな成長機会を提供すると期待されています。しかし、実験室での形質転換パラメータの複雑さが、市場成長を制限する課題となっています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場洞察

  • 市場概要
  • 促進要因
    • バイオ医薬品市場の成長
    • 組換えタンパク質に対する需要の高まり
    • ライフサイエンス研究に対する政府の取り組みと資金の増加
  • 抑制要因
    • 熟練専門家の不足
    • タンパク質ベースの研究コストの高さ
  • 機会
    • 潜在的な新興経済国
  • 課題
    • 実験室での変換パラメータの複雑さ
  • 業界動向
  • 親 / 隣接市場分析
  • 規制分析

第5章 タンパク質発現市場評価:システム別

  • 概要
  • 哺乳類細胞発現システム
    • チャイニーズハムスター卵巣(CHO)細胞株
    • HEK 293細胞株
    • その他の哺乳類細胞株
  • 非哺乳動物細胞発現系
    • 細菌細胞株
    • 昆虫細胞株
    • 酵母細胞株
    • 植物細胞株
    • 藻類細胞ライン
  • 無細胞発現システム

第6章 タンパク質発現市場評価:製品・サービス別

  • 概要
  • 機器
  • キット・試薬
  • コンピテントセル
    • 化学的コンピテントセル
    • エレクトロコンピテントセル
  • 発現ベクター
  • サービス

第7章 タンパク質発現市場評価:用途別

  • 概要
  • 治療用途
  • 産業応用
  • 研究用途

第8章 タンパク質発現市場評価:エンドユーザー別

  • イントロダクション
  • 製薬・バイオテクノロジー産業
  • 開発業務受託機関(CRO)
  • 学術・研究機関

第9章 タンパク質発現市場評価:地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • その他アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合分析

  • 概要
  • 主要成長戦略
  • 競合ベンチマーキング
  • 競合ダッシュボード
    • 業界リーダー
    • 市場差別化要因
    • 先行企業
    • 新興企業
  • 市場シェア分析(2022年)

第11章 企業プロファイル(企業概要、財務概要、製品ポートフォリオ、戦略的展開)

  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Takara Holdings Inc.
  • GenScript Biotech Corporation
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Danaher Corporation
  • BECTON, DICKINSON AND COMPANY

(注:上位5社のSWOT分析を提供予定です)

第12章 付録

図表

LIST OF TABLES

  • Table 1 Global Protein Expression Market Drivers: Impact Analysis (2024-2030)
  • Table 2 Global Protein Expression Market Restraint: Impact Analysis (2024-2030)
  • Table 3 Global Protein Expression Market Restraints: Impact Analysis (2024-2030)
  • Table 4 Global Protein Expression Market Opportunities: Impact Analysis (2024-2030)
  • Table 5 Global Protein Expression Market Challenges: Impact Analysis (2024-2030)
  • Table 6 Global Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 7 Global Mammalian Cell Expression System Market, by Type, 2021-2030 (USD Million)
  • Table 8 Global Mammalian Cell Expression System Market, by Country/Region, 2021-2030 (USD Million)
  • Table 9 Vendors Offering Mammalian Cell Expression System
  • Table 10 Global Chinese Hamster Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 11 Global HEK 293 Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 12 Global Other Mammalian Cell Expression System Market, by Country/Region, 2021-2030 (USD Million)
  • Table 13 Global Non-mammalian Cell Expression System Market, by Country/Region, 2021-2030 (USD Million)
  • Table 14 Global Bacterial Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 15 Global Insect Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 16 Global Yeast Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 17 Global Plant Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 18 Global Algal Cell Lines Market, by Country/Region, 2021-2030 (USD Million)
  • Table 19 Global Cell-free Expression System Market, by Country/Region, 2021-2030 (USD Million)
  • Table 20 Global Other Expression Systems Market, by Country/Region, 2021-2030 (USD Million)
  • Table 21 Global Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 22 Global Instruments Market for Protein Expression, by Country/Region, 2021-2030 (USD Million)
  • Table 23 Global Kits & Reagents Market for Protein Expression, by Country/Region, 2021-2030 (USD Million)
  • Table 24 Global Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 25 Global Chemically Competent Cells Market for Protein Expression, by Country/Region, 2021-2030 (USD Million)
  • Table 26 Global Electrocompetent Cells Market for Protein Expression, by Country/Region, 2021-2030 (USD Million)
  • Table 27 Global Expression Vectors Market for Protein Expression, by Country/Region, 2021-2030 (USD Million)
  • Table 28 Global Protein Expression Services Market, by Country/Region, 2021-2030 (USD Million)
  • Table 29 Global Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 30 Global Protein Expression Market for Therapeutics, by Country/Region, 2021-2030 (USD Million)
  • Table 31 Global Protein Expression Market for Research, by Country/Region, 2021-2030 (USD Million)
  • Table 32 Global Protein Expression Market for Industrial, by Country/Region, 2021-2030 (USD Million)
  • Table 33 Global Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 34 Global Protein Expression Market for Pharmaceutical and Biotechnology Industry, by Type, 2021-2030 (USD Million)
  • Table 35 Global Protein Expression Market for Contract Research Organizations, by Country/Region, 2021-2030 (USD Million)
  • Table 36 Global Protein Expression Market for Academic and Research Institutes, by Country/Region, 2021-2030 (USD Million)
  • Table 37 Global Protein Expression Market, by Country/Region, 2021-2030 (USD Million)
  • Table 38 North America: Protein Expression Market, by Country, 2021-2030 (USD Million)
  • Table 39 North America: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 40 North America: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 41 North America: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 42 North America: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 43 North America: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 44 North America: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 45 North America: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 46 U.S.:Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 47 U.S.: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 48 U.S.: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 49 U.S.: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 50 U.S.: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 51 U.S.: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 52 U.S.: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 53 Canada: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 54 Canada: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 55 Canada: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 56 Canada: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 57 Canada: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 58 Canada: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 59 Canada: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 60 Europe: Protein Expression Market, by Country, 2021-2030 (USD Million)
  • Table 61 Europe: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 62 Europe: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 63 Europe: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 64 Europe: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 65 Europe: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 66 Europe: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 67 Europe: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 68 Germany: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 69 Germany: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 70 Germany: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 71 Germany: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 72 Germany: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 73 Germany: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 74 Germany: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 75 France: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 76 France: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 77 France: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 78 France: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 79 France: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 80 France: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 81 France: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 82 U.K.: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 83 U.K.: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 84 U.K.: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 85 U.K.: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 86 U.K.: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 87 U.K.: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 88 U.K.: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 89 Italy: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 90 Italy: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 91 Italy: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 92 Italy: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 93 Italy: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 94 Italy: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 95 Italy: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 96 Spain: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 97 Spain: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 98 Spain: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 99 Spain: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 100 Spain: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 101 Spain: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 102 Spain: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 103 RoE: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 104 RoE: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 105 RoE: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 106 RoE: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 107 RoE: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 108 RoE: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 109 RoE: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 110 APAC: Protein Expression Market, by Country, 2021-2030 (USD Million)
  • Table 111 APAC: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 112 APAC: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 113 APAC: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 114 APAC: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 115 APAC: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 116 APAC: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 117 APAC: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 118 Japan: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 119 Japan: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 120 Japan: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 121 Japan: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 122 Japan: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 123 Japan: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 124 Japan: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 125 China: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 126 China: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 127 China: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 128 China: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 129 China: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 130 China: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 131 China: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 132 India: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 133 India: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 134 India: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 135 India: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 136 India: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 137 India: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 138 India: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 139 RoAPAC: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 140 RoAPAC: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 141 RoAPAC: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 142 RoAPAC: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 143 RoAPAC: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 144 RoAPAC: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 145 RoAPAC: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 146 Latin America: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 147 Latin America: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 148 Latin America: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 149 Latin America: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 150 Latin America: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 151 Latin America: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 152 Latin America: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 153 Middle East & Africa: Protein Expression Market, by System Type, 2021-2030 (USD Million)
  • Table 154 Middle East & Africa: Mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 155 Middle East & Africa: Non-mammalian Cell Expression Systems Market, by Type, 2021-2030 (USD Million)
  • Table 156 Middle East & Africa: Protein Expression Market, by Product & Service, 2021-2030 (USD Million)
  • Table 157 Middle East & Africa: Competent Cells Market for Protein Expression, by Type, 2021-2030 (USD Million)
  • Table 158 Middle East & Africa: Protein Expression Market, by Application, 2021-2030 (USD Million)
  • Table 159 Middle East & Africa: Protein Expression Market, by End User, 2021-2030 (USD Million)
  • Table 160 Recent Developments, by Company, 2020-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Estimation
  • Figure 7 Global Protein Expression Market, by System Type, 2024 Vs. 2030 (USD Million)
  • Figure 8 Global Protein Expression Market, by Product & Service, 2024 Vs. 2030 (USD Million)
  • Figure 9 Global Protein Expression Market, by Application, 2024 Vs. 2030 (USD Million)
  • Figure 10 Global Protein Expression Market, by End User, 2024 Vs. 2030 (USD Million)
  • Figure 11 Global Protein Expression Market, by Geography, 2024 Vs. 2030 (USD Million)
  • Figure 12 North America: Protein Expression Market Snapshot
  • Figure 13 Asia-Pacific: Protein Expression Market Snapshot
  • Figure 14 Europe: Protein Expression Market Snapshot
  • Figure 15 Key Growth Strategies Adopted by Leading Players, 2020-2024
  • Figure 16 Protein Expression: Competitive Benchmarking, by System Type
  • Figure 17 Protein Expression: Competitive Benchmarking, by Geography
  • Figure 18 Market Share Analysis: Protein Expression Industry, 2022
  • Figure 19 Thermo Fisher Scientific Inc.: Financial Overview (2022)
  • Figure 20 Promega Corporation: Financial Overview (2022)
  • Figure 21 Merck KGaA: Financial Overview (2022)
  • Figure 22 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
  • Figure 23 Takara Holdings Inc.: Financial Overview (2022)
  • Figure 24 GenScript Biotech Corporation: Financial Overview (2022)
  • Figure 25 Qiagen N.V.: Financial Overview (2022)
  • Figure 26 Agilent Technologies, Inc.: Financial Overview (2022)
  • Figure 27 Danaher Corporation: Financial Overview (2022)
  • Figure 28 BECTON, DICKINSON AND COMPANY: Financial Overview (2022)
目次
Product Code: MRHC - 104932

Protein Expression Market Size, Share, Forecast, & Trends Analysis by System (Mammalian [CHO, HEK 293], Non-mammalian [Bacterial, Insect]), Offering (Kits & Reagents, Competent Cells, Services), Application, and End User - Global Forecast to 2030

The protein expression market is projected to reach $5 billion by 2030 at a CAGR of 7.6% from 2023 to 2030.

Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.

The growing biopharmaceutical market, the rising demand for recombinant proteins, supportive government initiatives, and funding for life science research are driving the growth of this market. However, the high costs of protein-based research and the lack of skilled professionals restrain the growth of this market. Furthermore, emerging economies are expected to offer significant growth opportunities for players operating in the protein expression market. However, complexities in laboratory transformation parameters are a challenge limiting market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the protein expression market are Thermo Fisher Scientific Inc. (U.S.), Promega Corporation (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Takara Holdings Inc. (Japan), GenScript Biotech Corporation (U.S.), Qiagen N.V. (Germany), Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), and Becton, Dickinson and Company (U.S.).

Based on system, in 2023, the Chinese Hamster Ovary (CHO) cell line segment is expected to account for the largest share of the mammalian protein expression market. The large market share of this segment is attributed to the popularity of CHO cell lines in the production of biologics, the high similarity of CHO cells to the human cell system, and the high reproducibility of CHO cells.

Based on offering, the services segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is driven by the increasing outsourcing of operations by pharma & biotech companies, the rising demand for biopharmaceuticals, collaborations between industry and academia for rapid bioproduction, and the growing demand for recombinant proteins in the non-healthcare sector.

Based on application, in 2023, the therapeutic segment is estimated to account for the largest share of the protein expression market. The large market share of this segment is attributed to the increasing incidence of diseases requiring therapeutic approaches for treatment and growth in R&D for therapeutic protein production.

Based on end user, in 2023, the contract research organizations segment is estimated to account for the largest share of the protein expression market. The large market share of this segment can be attributed to the increase in research activities and growth in outsourcing for the development of biologics.

An in-depth analysis of the geographical scenario in the protein expression market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the protein expression market. Furthermore, in 2023, the U.S. is expected to account for the major share of the protein expression market in North America. The large share of this market is primarily attributed to the presence of key market players, growth in R&D activities, and the significant volume of bioproduction.

Scope of the Report:

Protein Expression Market Assessment-by System

  • Mammalian Cell Expression Systems
    • Chinese Hamster Ovary (CHO) Cell Lines
    • HEK 293 Cell Lines
    • Other Mammalian Cell Lines
  • Non-mammalian Cell Expression Systems
    • Bacterial Cell Lines
    • Insect Cell Lines
    • Yeast Cell Lines
    • Plant Cell Lines
    • Algal-based Cell Lines
  • Cell-free Expression System

Note: Other mammalian cell lines include baby hamster kidney cells, non-secreting murine myeloma cells, and PER.C6.

Protein Expression Market Assessment-by Offering

  • Instruments
  • Kits & Reagents
  • Competent Cells
    • Chemically Competent Cells
    • Electrocompetent Cells
  • Expression Vectors
  • Services

Protein Expression Market Assessment-by Application

  • Therapeutic
  • Research
  • Industrial

Protein Expression Market Assessment-by End User

  • Pharmaceutical & Biotechnology Industry
  • Contract Research Organizations
  • Academic & Research Institutes

Protein Expression Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Process of Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for this Study

3. Executive Summary

4. Market Insights

  • 4.1. Market Overview
  • 4.2. Drivers
    • 4.2.1. Growth in the Biopharmaceutical Market
    • 4.2.2. Growing Demand for Recombinant Proteins
    • 4.2.3. Rising Government Initiatives and Funding for Life Science Research
  • 4.3. Restraints
    • 4.3.1. Shortage of Skilled Professionals
    • 4.3.2. High Cost of Protein-based Research
  • 4.4. Opportunities
    • 4.4.1. Potential Emerging Economies
  • 4.5. Challenges
    • 4.5.1. Complexities in Laboratory Transformation Parameters
  • 4.6. Industry Trends
  • 4.7. Parent/Adjacent Market Analysis
  • 4.8. Regulatory Analysis

5. Protein Expression Market Assessment-by System

  • 5.1. Overview
  • 5.2. Mammalian Cell Expression System
    • 5.2.1. Chinese Hamster Ovary (CHO) Cell Lines
    • 5.2.2. HEK 293 Cell Lines
    • 5.2.3. Other Mammalian Cell Lines
  • 5.3. Non-mammalian Cell Expression System
    • 5.3.1. Bacterial Cell Lines
    • 5.3.2. Insect Cell Lines
    • 5.3.3. Yeast Cell Lines
    • 5.3.4. Plant Cell Lines
    • 5.3.5. Algal Cell Lines
  • 5.4. Cell-Free Expression System

6. Protein Expression Market Assessment-by Product & Services

  • 6.1. Overview
  • 6.2. Instruments
  • 6.3. Kits & Reagents
  • 6.4. Competent Cells
    • 6.4.1. Chemically Competent Cells
    • 6.4.2. Electrocompetent Cells
  • 6.5. Expression Vectors
  • 6.6. Services

7. Protein Expression Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Therapeutic Application
  • 7.3. Industrial Application
  • 7.4. Research Application

8. Protein Expression Market Assessment-by End User

  • 8.1. Introduction
  • 8.2. Pharmaceutical and Biotechnology Industry
  • 8.3. Contract Research Organizations (CROs)
  • 8.4. Academic and Research Institutes

9. Protein Expression Market Assessment-by Geography

  • 9.1. Overview
  • 9.2. North America
    • 9.2.1. U.S.
    • 9.2.2. Canada
  • 9.3. Europe
    • 9.3.1. Germany
    • 9.3.2. France
    • 9.3.3. U.K.
    • 9.3.4. Italy
    • 9.3.5. Spain
    • 9.3.6. Rest of Europe
  • 9.4. Asia-Pacific
    • 9.4.1. China
    • 9.4.2. India
    • 9.4.3. Japan
    • 9.4.4 Rest of Asia-Pacific
  • 9.5. Latin America
  • 9.6. Middle East & Africa

10. Competition Analysis

  • 10.1. Overview
  • 10.2. Key Growth Strategies
  • 10.3. Competitive Benchmarking
  • 10.4. Competitive Dashboard
    • 10.4.1. Industry Leaders
    • 10.4.2. Market Differentiators
    • 10.4.3. Vanguards
    • 10.4.4. Emerging Companies
  • 10.5. Market Share Analysis (2022)

11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments)

  • 11.1. Thermo Fisher Scientific Inc.
  • 11.2. Promega Corporation
  • 11.3. Merck KGaA
  • 11.4. Bio-Rad Laboratories, Inc.
  • 11.5. Takara Holdings Inc.
  • 11.6. GenScript Biotech Corporation
  • 11.7. Qiagen N.V.
  • 11.8. Agilent Technologies, Inc.
  • 11.9. Danaher Corporation
  • 11.10. BECTON, DICKINSON AND COMPANY

(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)

12. Appendix

  • 12.1. Available Customization
  • 12.2. Related Reports